[1] | Improved Healing of Split Thickness Skin Graft Donor Sites [Internet]. Available from:http://www.jrnlappliedresearch.com/articles/Vol2Iss2/Atiyehspr02.htm. |
[2] | Badalian-Very G, Vergilio J-A, Fleming M, Rollins BJ. Pathogenesis of Langerhans Cell Histiocytosis. Annu Rev Pathol Mech Dis [Internet]. Annual Reviews ; 2013 Jan 24 [cited 2016 Sep 25];8(1):1–20. Available from: http://www.annualreviews.org/doi/10.1146/annurev-pathol-020712-163959. |
[3] | Baumgartner I, von Hochstetter A, Baumert B, Luetolf U, Follath F. Langerhans’-cell histiocytosis in adults. Med Pediatr Oncol [Internet]. Wiley Subscription Services, Inc., A Wiley Company; 1997 Jan [cited 2016 Sep 25]; 28(1): 9–14. Available from: http://0x9.me/If7Wl. |
[4] | Jeziorski E, Senechal B, Molina TJ, Devez F, Leruez-Ville M, Morand P, et al. Herpes-Virus Infection in Patients with Langerhans Cell Histiocytosis: A Case-Controlled Sero-Epidemiological Study, and In Situ Analysis. Masucci MG, editor. PLoS One [Internet]. Public Library of Science; 2008 Sep 23 [cited 2016 Sep 25]; 3(9): e3262. Available from: http://dx.plos.org/10.1371/journal.pone.0003262. |
[5] | Badalian-Very G, Vergilio J-A, Degar BA, MacConaill LE, Brandner B, Calicchio ML, et al. Recurrent BRAF mutations in Langerhans cell histiocytosis. Blood [Internet]. American Society of Hematology; 2010 Sep 16 [cited 2016 Sep 25]; 116(11): 1919–23. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20519626. |
[6] | Chakraborty R, Hampton OA, Shen X, Simko SJ, Shih A, Abhyankar H, et al. Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis. Blood [Internet]. American Society of Hematology; 2014 Nov 6 [cited 2016 Sep 25]; 124(19): 3007–15. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25202140. |
[7] | Histiocytosis syndromes in children. Writing Group of the Histiocyte Society. Lancet (London, England) [Internet]. 1987 Jan 24 [cited 2016 Sep 26];1(8526):208–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2880029. |
[8] | Favara BE, Feller AC, Pauli M, Jaffe ES, Weiss LM, Arico M, et al. Contemporary classification of histiocytic disorders. The WHO Committee On Histiocytic/Reticulum Cell Proliferations. Reclassification Working Group of the Histiocyte Society. Med Pediatr Oncol [Internet]. 1997 Sep [cited 2016 Sep 25]; 29(3): 157–66. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9212839. |
[9] | Odame I, Li P, Lau L, Doda W, Noseworthy M, Babyn P, et al. Pulmonary Langerhans cell histiocytosis: a variable disease in childhood. Pediatr Blood Cancer [Internet]. 2006 Dec [cited 2016 Sep 26]; 47(7): 889–93. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16276522. |
[10] | Grois N, Pötschger U, Prosch H, Minkov M, Arico M, Braier J, et al. Risk factors for diabetes insipidus in langerhans cell histiocytosis. Pediatr Blood Cancer [Internet]. Wiley Subscription Services, Inc., A Wiley Company; 2006 Feb [cited 2016 Sep 25]; 46(2): 228–33. Available from: http://doi.wiley.com/10.1002/pbc.20425. |
[11] | Egeler RM, Neglia JP, Aricò M, Favara BE, Heitger A, Nesbit ME, et al. The relation of Langerhans cell histiocytosis to acute leukemia, lymphomas, and other solid tumors. The LCH-Malignancy Study Group of the Histiocyte Society. Hematol Oncol Clin North Am [Internet]. 1998 Apr [cited 2016 Sep 25];12(2):369–78. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9561906. |
[12] | Newman B, Hu W, Nigro K, Gilliam AC. Aggressive histiocytic disorders that can involve the skin. J Am Acad Dermatol [Internet]. 2007 Feb [cited 2016 Sep 25]; 56(2): 302–16. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17097374. |
[13] | Munn S, Chu AC. Langerhans cell histiocytosis of the skin. Hematol Oncol Clin North Am [Internet]. 1998 Apr [cited 2016 Sep 25]; 12(2): 269–86. Available from: http://www.ncbi.nlm.nih.gov/pubmed/9561900. |
[14] | Kapur P, Erickson C, Rakheja D, Carder KR, Hoang MP. Congenital self-healing reticulohistiocytosis (Hashimoto-Pritzker disease): ten-year experience at Dallas Children’s Medical Center. J Am Acad Dermatol [Internet]. 2007 Feb [cited 2016 Sep 25]; 56(2): 290–4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17224372. |
[15] | Annibali S, Cristalli M, Solidani M, Ciavarella D, La Monaca G, Suriano M, et al. Langerhans cell histiocytosis: oral/periodontal involvement in adult patients. Oral Dis [Internet]. Blackwell Publishing Ltd; 2009 Nov [cited 2016 Sep 25]; 15(8): 596–601. Available from: http://doi.wiley.com/10.1111/j.1601-0825.2009.01601.x. |
[16] | Myers E, Shea CR, Krausz T, Petronic-Rosic V. Eosinophilic granuloma of the skin: response to intralesional corticosteroid injection. J Drugs Dermatol [Internet]. 2007 Mar [cited 2016 Sep 25]; 6(3): 329–32. Available from: http://www.ncbi.nlm.nih.gov/pubmed/17373196. |
[17] | Imanaka A, Tarutani M, Itoh H, Kira M, Itami S. Langerhans Cell Histiocytosis Involving the Skin of an Elderly Woman: A Satisfactory Remission with Oral Prednisolone Alone. J Dermatol [Internet]. 2004 Dec [cited 2016 Sep 25]; 31(12): 1023–6. Available from: http://doi.wiley.com/10.1111/j.1346-8138.2004.tb00648.x. |
[18] | Hoeger PH, Nanduri VR, Harper JI, Atherton DA, Pritchard J. Long term follow up of topical mustine treatment for cutaneous langerhans cell histiocytosis. Arch Dis Child [Internet]. BMJ Publishing Group Ltd and Royal College of Paediatrics and Child Health; 2000 Jun [cited 2016 Sep 25]; 82(6): 483–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10833183. |
[19] | Taverna JA, Stefanato CM, Wax FD, Demierre M-F. Adult cutaneous Langerhans cell histiocytosis responsive to topical imiquimod. J Am Acad Dermatol [Internet]. 2006 May [cited 2016 Sep 26]; 54(5): 911–3. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16635684. |
[20] | Rieker J, Hengge U, Ruzicka T, Bruch-Gerharz D. Multifokales Granuloma eosinophilicum faciei. Der Hautarzt [Internet]. Springer Berlin Heidelberg; 2006 Apr 11 [cited 2016 Sep 25]; 57(4): 324–6. Available from: http://link.springer.com/10.1007/s00105-006-1112-0. |
[21] | Steen AE, Steen KH, Bauer R, Bieber T. Successful treatment of cutaneous Langerhans cell histiocytosis with low-dose methotrexate. Br J Dermatol [Internet]. 2001 Jul [cited 2016 Sep 26]; 145(1): 137–40. Available from: http://www.ncbi.nlm.nih.gov/pubmed/11453923. |
[22] | Sander CS, Kaatz M, Elsner P. Successful treatment of cutaneous langerhans cell histiocytosis with thalidomide. Dermatology [Internet]. 2004 [cited 2016 Sep 26]; 208(2): 149–52. Available from: http://www.ncbi.nlm.nih.gov/pubmed/15057007. |
[23] | Tsambaos D, Georgiou S, Kapranos N, Monastirli A, Stratigos A, Berger H. Langerhans’ cell histiocytosis: complete remission after oral isotretinoin therapy. Acta Derm Venereol [Internet]. 1995 Jan [cited 2016 Sep 25]; 75(1): 62–4. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7747539. |
[24] | Imafuku S, Shibata S, Tashiro A, Furue M. Cutaneous Langerhans cell histiocytosis in an elderly man successfully treated with narrowband ultraviolet B. Br J Dermatol [Internet]. Blackwell Publishing Ltd; 2007 Dec [cited 2016 Sep 25]; 157(6): 1277–9. Available from: http://doi.wiley.com/10.1111/j.1365-2133.2007.08204.x. |
[25] | Sakai H, Ibe M, Takahashi H, Matsuo S, Okamoto K, Makino I, et al. Satisfactory Remission Achieved by PUVA Therapy in Langerhans Cell Hisiocytosis in an Elderly Patient. J Dermatol [Internet]. 1996 Jan [cited 2016 Sep 25]; 23(1): 42–6. Available from: http://doi.wiley.com/10.1111/j.1346-8138.1996.tb03966.x. |
[26] | Chang SE, Koh GJ, Choi JH, Lee KH, Sung KJ, Moon KC, et al. Widespread skin-limited adult Langerhans cell histiocytosis: Long-term follow-up with good response to interferon alpha. Clin Exp Dermatol [Internet]. Blackwell Science Ltd; 2002 Mar [cited 2016 Sep 25]; 27(2): 135–7. Available from: http://doi.wiley.com/10.1046/j.1365-2230.2002.00989.x. |
[27] | Fistarol S, Itin P, Häusermann P, Oberholzer M, Raineri I, Lambrecht T, et al. Unifocal Langerhans cell histiocytosis of the oral mucosa. J der Dtsch Dermatologischen Gesellschaft [Internet]. Blackwell Publishing Ltd; 2009 Jul [cited 2016 Sep 25]; 7(7): 620–2. Available from: http://doi.wiley.com/10.1111/j.1610-0387.2009.07042.x. |
[28] | Selch MT, Parker RG. Radiation therapy in the management of Langerhans cell histiocytosis. Med Pediatr Oncol [Internet]. 1990 [cited 2016 Sep 25]; 18(2): 97–102. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2304426. |
[29] | Arceci RJ, Longley BJ, Emanuel PD. Atypical cellular disorders. Hematology Am Soc Hematol Educ Program [Internet]. American Society of Hematology; 2002 [cited 2016 Sep 25]; 2002(1): 297–314. Available from: http://www.ncbi.nlm.nih.gov/pubmed/12446429. |
[30] | Harris GJ, Woo KI. Eosinophilic granuloma of the orbit: a paradox of aggressive destruction responsive to minimal intervention. Trans Am Ophthalmol Soc [Internet]. American Ophthalmological Society; 2003 [cited 2016 Sep 25]; 101: 93–103; discussion 103–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/14971567. |
[31] | Putters TF, de Visscher JGAM, van Veen A, Spijkervet FKL. Intralesional infiltration of corticosteroids in the treatment of localised langerhans’ cell histiocytosis of the mandible Report of known cases and three new cases. Int J Oral Maxillofac Surg [Internet]. 2005 Jul [cited 2016 Sep 25]; 34(5): 571–5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/16053880. |